Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion type Assertion NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_head.
- NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_provenance.
- NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion evidence source_evidence_literature NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_provenance.
- NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion SIO_000772 15838384 NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_provenance.
- NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion wasDerivedFrom befree-20150227 NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_provenance.
- NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion wasGeneratedBy ECO_0000203 NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_provenance.